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The impact of reduced red and processed meat
consumption on cardiovascular risk factors; an
intervention trial in healthy volunteers
Elizabeth J. Simpson, *b,c Marie Clark,a Azlina A. Razak b and Andrew Salter a,d
Meat represents an important part of the diet for many adults, supplying essential amino acids and micronu-
trients. However, high red and processed meat (RPM) intake is implicated in the development of cardio-
vascular disease and dyslipidemia. This study aimed to reduce RPM consumption in healthy, non-obese
omnivores (21–48 years), who ate RPM ≥4 times per week, and to investigate its eﬀect on cardiovascular
risk factors using a single-group longitudinal study design (comprising an initial 4-week baseline period, fol-
lowed by a 12-week intervention). Participants (16M : 21F) were assessed before (BL) and after (T0) the pre-
intervention period and before (T0), at week 6 (T6) and at the end of intervention (T12). In a subset
(8M : 15F), haematological parameters were measured at BL, T6 and T12. Compared with BL, protein intake
from RPM reduced by 67% at T6 and 47% at T12 (4-day dietary records). BMI, body fat mass, and blood
pressure did not change over the intervention in the whole cohort, but mean total, LDL and HDL cholesterol
were reduced in males at T12 (eﬀect sizes −0.52, −0.41 and −0.15 mmol l−1, respectively; each P < 0.01),
with no change in total : HDL ratio observed. In the study sub-set, haemoglobin concentration, plus red and
white cell count fell during the intervention (estimated eﬀect size ηp2 0.300, 0.301 and 0.354, respectively;
each P < 0.001). It was possible for omnivores to approximately halve their RPM intake, and in males this
dietary change appeared to reduce blood lipid concentrations. However, acute dietary changes to RPM
intake may have had an unfavourable impact on haematological parameters.
Introduction
Meat represents an important part of a healthy balanced diet
for many adults across the globe, supplying high quality
protein, essential amino acids and micronutrients such as
iron, vitamins A and B12, zinc, selenium and folic acid.
1 The
bioavailability and concentration of these micronutrients in
plant-derived foods are generally lower,1,2 and plant protein is
often of poorer quality (lower quantities of indispensable
amino acids and/or poorer bioavailability), requiring higher
intakes, or consumption of a combination of diﬀerent plant
sources. Indeed, the prevalence of some micronutrient
deficiencies seems to be greater in vegetarian and vegan
populations.3,4
The high protein and low carbohydrate properties of meat
results in a low glycaemic index (GI) for this food group, and
high protein-low GI diets are being recommended to improve
weight management following weight-loss.5,6 However, diets
high in red (pork, beef, lamb and veal) and processed meat
(meats that have been smoked, cured or preserved in some
way), have been implicated in the development of cardio-
vascular disease (CVD), and colon cancer.7,8 Indeed, data from
the Health Professionals Follow-up, and Nurses’ Health Study
indicate that those in the highest quintile of total red meat
consumption had a 40% higher risk of cardiovascular mor-
tality than those in the lowest.9
While the specific reason for the impact of red meat on
CVD risk remains to be established, such products can con-
tribute significantly to saturated fatty acid (SFA) intake, which
is directly associated with elevated serum total (TC) and LDL
cholesterol; risk factors for CVD.10,11 Atherosclerosis, the
underlying cause of CVD, develops over decades and it may be
important to reduce risk factors before the onset of clinical
manifestation.
In addition to the potential impact of meat consumption
on human health, there is increasing concern over the sustain-
ability of livestock production and its impact on the environ-
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ment in the face of global population growth and climate
change.12 As such, both the health issues associated with high
red meat consumption, together with the detrimental environ-
mental impact of livestock production, have culminated in
developed societies being encouraged to reduce meat
intake.13,14 This has resulted in a marked increase in the adop-
tion of vegetarian and vegan diets in numerous countries.
However, many omnivores still face significant barriers to
reducing meat intake,15,16 including a lack of knowledge and
understanding of the availability, preparation and nutritional
value of meat alternatives or meat substitutes.
The current study aimed to see whether a 50% reduction in
red and processed meat (RPM) intake could be achieved in
healthy, normal weight omnivores by encouraging the con-
sumption of reduced meat and meat-free meals, and to
monitor changes to blood lipid profile and other cardio-
vascular risk factors that might result from this behavioural
change.
Results
Participants
Initial interest was expressed by 55 individuals, 46 of whom
fulfilled inclusion criteria, and undertook the medical
screening. In total, 43 of these individuals (22F : 21M; BMI
18–28 kg m−2; aged 21–48 years) were suitable to participate.
Three individuals withdrew from the study before the interven-
tion, with 3 individuals withdrawing between assessment
visits T6 (6 weeks into the meat-reduction intervention) and
T12 (end of the intervention), citing other commitments and
lack of time as the reason for drop-out. Thirty-seven partici-
pants (16M : 21F) completed the protocol.
Although a matched group design was not specifically
employed in the current protocol, at baseline (BL; on recruit-
ment), male and female participants were similar with respect
to age, fasting blood glucose, HOMA-IR, serum total chole-
sterol, LDL and triacylglycerides (TAG), whilst females demon-
strated a higher serum HDL concentration when compared to
males (Table 1).
Dietary intake
Complete sets of diet diary data (4 time points) were collected
in 34 participants (16M : 18F). The median [25th–75th percen-
tile] relative reported frequency of eating RPM was 9 [7–11]
times per week at BL, 11 [5–12] at T0, 4 [2–7] at T6 and 5 [1–8]
times per week at T12, with 8 out of 34 participants (24%)
recording no RPM intake in their T12 diet diary. There were no
sex diﬀerences in the reduction in frequency of RPM consump-
tion, and 96% of the whole cohort reported reducing the
number of times they consumed these products per week.
Participants could also reduce their meat intake by changing
portion size, and during the intervention average protein
intake from RPM was significantly lower at both T6 and T12
when compared with BL (P < 0.005 in each case). However,
9 (3F : 6M) participants did not have a protein intake from
RPM that was ≥50% below BL intake at T6, with 5 (1F : 4M) of
these individuals also reporting a protein intake from RPM
that was not ≥50% below BL intake at T12. Protein intake
derived from RPM showed a strong trend (P = 0.052) to be
higher at T0 (end of the pre-intervention period) than at BL,
with over half (19 out of 32) reporting eating more at T0. Daily
protein intake provided by seafood, chicken, and dairy did not
change over the pre-intervention or intervention periods, and
intake from pulses and nuts (P < 0.001) and mycoprotein (P <
0.001) during the intervention was greater than at T0 (Fig. 1).
Over the pre-intervention period, no change in macronutri-
ent intake was seen in the whole cohort, and the macronutri-
ent composition of the diet (expressed as a percentage of total
energy intake) did not change over the pre-intervention or
intervention period (Table 2). However, in the whole cohort,
EI, total and saturated (SFA) dietary fat intake were lower at
both T6 and T12 compared with T0 (P < 0.05 in each case;
Table 2). When separated by sex, total fat intake in women was
reduced during the intervention (P < 0.05), with a trend for EI,
total fat and SFA intake to be lower in men (P = 0.087, P =
0.068 and P = 0.087, respectively). Carbohydrate intake during
the intervention period did not change in the whole cohort
or within sex, whereas a significant alteration in AOAC
fibre intake over the intervention was noted in the women
Fig. 1 Mean protein intake contributed by 7 food groups. seafood,
dairy, ‘starchy’ foods, chicken, pulses and nuts, mycoprotein
and red and processed meats. Error bars display the standard error of
the mean for each food grouping.
Table 1 Parameters at baseline (BL; n = 37). M, males (n = 16). F, females
(n = 21). BMI, body mass index. TC, total cholesterol. LDL, low-density
lipoprotein. HDL, high-density lipoprotein. TAG, triacylglycerides. Mean
values are expressed with standard deviation in parentheses; median
values1 are shown with the 25th and 75th percentile in square brackets.
P values for between-sex comparisons are shown in the ﬁnal column
All Male Female M vs. F
Age (y)1 27 [24–32] 27 [24–30] 27 [24–32] 0.964
BMI (kg m−2) 23.1 (2.29) 23.4 (1.67) 22.9 (2.70) 0.503
Fasting glucose
(mmol l−1)
4.07 (0.34) 4.16 (0.35) 4.00 (0.33) 0.173
HOMA-IR1 1.73 [1.40–2.14] 1.68 [1.21–1.96] 1.87 [1.54–2.34] 0.138
TC (mmol l−1) 3.87 (0.74) 3.75 (0.86) 3.96 (0.65) 0.408
LDL (mmol l−1) 2.11 (0.63) 2.24 (0.75) 2.01 (0.52) 0.303
HDL (mmol l−1) 1.37 (0.35) 1.14 (0.23) 1.54 (0.32) <0.001
TAG (mmol l−1) 0.67 (0.23) 0.68 (0.16) 0.67 (0.28) 0.945
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(P < 0.05). Similarly, in women, a trend for a diﬀerence in
protein intake over the intervention was seen (P = 0.066),
although no such change in protein intake was observed in
males (Table 2).
Anthropometry and blood pressure
At BL, all participants were normal weight, with mean BMI
being similar between men and women (Table 1). BMI did not
change between BL and T0, or over the intervention. Females
demonstrated higher percentage body fat than men (P <
0.001), but within sex, no changes to percentage body fat were
observed over the pre-intervention or the intervention period
(Table 3).
Males had higher systolic blood pressure (SBP) than
females throughout the study (P < 0.05). No change in SBP was
seen between BL and T0 in either sex, and SBP was the same
in females across the intervention. However, there was a weak
trend for a change in this variable to occur across the interven-
tion in men (P = 0.096), with a significant fall in SBP noted
between T6 and T12 (P < 0.05). Diastolic blood pressure was
similar between sexes, and this variable did not change in the
whole cohort across the pre-, or intervention period.
Lipids
Participants in the current study were not recruited on the
basis of specified circulating lipid concentrations, but the
mean concentration of lipid parameters reflect the ‘healthy’10
nature of the cohort (Table 1). However, two participants
(1M : 1F) demonstrated fasting TC values above the healthy
range at the start of the study, with ten (7M : 3F) having LDL
values above 2.6 mmol l−1, although all were below a concen-
tration which would require therapeutic intervention, in the
UK, in otherwise healthy individuals.17 The response of serum
Table 2 Macronutrient dietary intake during the pre-intervention (BL and T0) and intervention (T6 and T12) periods (n = 34). SFA, saturated fatty
acids. PUFA, polyunsaturated fatty acids. CHO, carbohydrate. Fibre, AOAC ﬁbre. % Fat, percentage of total daily energy intake provided by fat. %
Protein, percentage provided by protein. % CHO, percentage provided by carbohydrate. Mean values are expressed with standard deviation in par-
entheses, median values are shown with the 25th and 75th percentile in square brackets. *P < 0.05 compared to pre-intervention (T0)
BL T0 T6 T12
Energy (kJ) Men 9862 [9203–11 641] 10 635 [9003–10 971] 9081 [7350–9922] 9153 [6678–11 544]
Women 8684 [8066–10 091] 8713 [7712–11 058] *7974 [6650–8917] 7974 [6721–9730]
All 9395 [8295–10 953] 10 295 [7988–10 952] *8472 [7018–9414] *8328 [6782–10 132]
Total fat (g) Men 96.8 [79.3–112.6] 106.2 [89.3–136.3] 83.1 [65.8–92.1] 89.1 [73.0–110.0]
Women 86.7 [72.2–103.7] 80.9 [67.3–104.9] 76.9 [56.8–91.5] 70.3 [58.5–87.2]
All 89.7 [77.7–109.9] 91.0 [74.4–125.3] *79.7 [61.1–91.8] *79.0 [64.9–102.0]
SFA (g) Men 34.3 [28.6–43.1] 37.2 [26.8–48.9] 25.4 [22.4–35.9] 32.2 [24.0–38.8]
Women 30.3 [25.5–38.2] 28.2 [25.4–34.8] 23.3 [17.3–31.1] 22.1 [18.0–30.2]
All 30.9 [26.3–41.6] 32.4 [25.6–44.4] *25.0 [18.6–32.3] *26.9 [21.4–35.2]
PUFA (g) Men 9.8 [12.8–14.7] 8.5 [11.8–16.3] 9.9 [12.8–16.2] 11.3 [14.5–17.1]
Women 9.2 [11.8–16.1] 9.2 [11.6–17.4] 7.9 [11.8–15.6] 8.1 [10.5–14.5]
All 9.6 [12.1–15.5] 8.7 [11.6–16.6] 8.5 [12.7–15.6] 8.93 [12.7–16.5]
Protein (g) Men 122.2 [98.7–143.9] 114.0 [91.5–142.4] 102.5 [84.7–124.8] 112.2 [97.3–126.7]
Women 85.0 [74.0–112.4] 95.6 [78.5–117.5] 76.9 [60.5–98.8] 89.8 [73.5–104.7]
All 101.1 [82.2–125.3] 100.2 [79.1–125.0] 92.1 [68.2–105.7] 98.3 [84.7–115.1]
CHO (g) Men 269.4 (81.1) 271.5 (73.0) 262.6 (82.1) 254.4 (93.5)
Women 258.7 (75.7) 248.6 (68.0) 219.6 (59.2) 235.6 (56.1)
All 263.8 (77.3) 259.4 (70.3) 240.0 (73.1) 244.5 (75.4)
Fibre (g) Men 21.7 (5.3) 23.1 (6.4) 25.8 (4.9) 26.2 (8.0)
Women 24.0 (10.7) 24.0 (10.3) 22.3 (8.4) 26.5 (9.2)
All 22.9 (8.6) 23.6 (8.6) 24.0 (7.1) 26.3 (8.5)
% Fat Men 35.5 [32.0–38.5] 39.0 [34.0–43.3] 34.5 [28.0–41.5] 35.5 [32.3–38.0]
Women 37.0 [33.5–39.0] 37.5 [32.0–41.3] 35.0 [32.3–41.0] 34.0 [30.0–38.0]
All 36.0 [32.0–39.0] 38.0 [32.8–41.3] 35.0 [30.0–41.0] 35.0 [31.0–38.0]
% Protein Men 20.0 (3.6) 18.8 (4.5) 19.2 (4.3) 20.2 (4.6)
Women 16.7 (2.7) 17.7 (3.9) 17.2 (3.9) 18.9 (4.5)
All 18.3 (3.5) 18.2 (4.1) 18.2 (4.2) 19.5 (4.5)
% CHO Men 41.3 (10.9) 41.9 (12.2) 45.6 (9.6) 43.1 (7.0)
Women 45.6 (7.0) 43.3 (7.7) 45.0 (9.2) 46.1 (7.0)
All 43.5 (9.2) 42.7 (9.9) 45.3 (9.3) 44.7 (7.1)
Table 3 Anthropometric and blood pressure measurements during the
pre-intervention period (BL and T0) and intervention (T6 and T12)
periods. Where sex diﬀerences were noted at BL, data are presented for
males (M; n = 16) and females (F; n = 21) separately. Where no such
diﬀerences were observed, data have been combined and are displayed
for the whole cohort (n = 37). SBP, systolic blood pressure. DBP, systolic
blood pressure. Mean values are expressed with the standard deviation
in parentheses; median values1 are shown with the 25th and 75th per-
centile in square brackets. Between sex comparisons at BL, *P < 0.05,
**P < 0.01
BL T0 T6 T12
BMI (kg m−2) All 23.1 (2.29) 23.3 (2.41) 23.3 (2.43) 23.3 (2.42)
Body fat (%) M **13.8 (3.6) 14.9 (4.5) 13.6 (4.3) 14.3 (4.5)
F 27.2 (6.1) 26.7 (6.6) 28.9 (5.9) 26.4 (6.2)
All 21.7 (8.4) 21.8 (8.2) 20.8 (8.0) 21.4 (8.2)
SBP (mmHg) M *116 (8.7) 115 (10.7) 118 (9.3) 112 (9.1)
F 109 (10.8) 108 (10.1) 108 (10.8) 108 (11.8)
All 112 (10.6) 111 (10.8) 112 (11.1) 110 (10.8)
DBP1 (mmHg) All 68 [66–69] 67 [62–71] 67 [64–73] 67 [62–72]
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LDL to the intervention was diﬀerent in men and women
(P < 0.05), with LDL falling significantly over the 12 weeks in
the male participants (P < 0.01), but remaining unchanged in
the females (Fig. 2a). In females, there was no change in LDL
during the pre-intervention period, whereas in males this vari-
able increased at T0 when compared with BL. In men, serum
LDL was significantly lower at the end of the intervention com-
pared to T0 (P < 0.01). However, serum LDL concentration was
not significantly lower at T12 when compared to values
observed at BL. In males, there was a significant correlation
between the concentration of serum LDL at the start of the
intervention (T0) and the change in this variable at the end of
the intervention (R = 0.771, P < 0.001), with those starting with
higher serum LDL demonstrating greater reduction over the 12
weeks intervention. Furthermore, the concentration of serum
LDL at BL remained significantly associated (R = 0.735,
P < 0.001) with a change in this variable at the end of the inter-
vention (T12), with no such correlation observed in females
irrespective of whether LDL concentration at T0 or BL was
used as the comparator to T12.
In males, LDL concentration was significantly, albeit
weakly, correlated with dietary total fat intake (R = 0.251; P <
0.05) and negatively correlated with AOAC fibre intake (R =
−0.274; P < 0.05), with a trend for a positive correlation with
dietary cholesterol consumption (R = 0.231; P = 0.067). There
was no co-linearity detected between total fat and AOAC
fibre intake, and a combined regression model accounted
for 32% of the variance in serum LDL concentration in men
(P < 0.001). In women, a significant association between
LDL and reported dietary fat and cholesterol intake was not
observed, although a correlation between this variable and
AOAC fibre intake, of a similar magnitude to that seen in men,
was noted (R = −0.249; P < 0.05).
Fasting serum HDL concentration did not change between
BL and T0 in either sex (Fig. 2b). Similarly, no changes in HDL
were noted over the intervention period in the female partici-
pants. However, there was a significant reduction in HDL con-
centration over the intervention in men (P < 0.05) with this
variable being lower at T12 when compared with T0 (P < 0.01),
but also significantly lower when compared to values
measured at BL (P < 0.05). It is worth noting that total
cholesterol : HDL ratio did not change over the intervention in
males (ratio at BL 3.49 vs. 3.52 at T12).
Serum total cholesterol (TC) data largely reflect the changes
observed in LDL and HDL, with the response of TC to the
intervention being diﬀerent in men and women (P < 0.05), and
serum TC falling significantly over the 12 weeks in the male
participants (eﬀect size ηp2 0.270; P < 0.01), but remaining
unchanged in females. Similarly, in females there was no
change in mean TC from BL to T0 (−0.03 (0.65) mmol l−1),
whereas in males this variable increased over this time frame
(0.34 (0.55) mmol l−1; P < 0.05). In men, serum TC was signifi-
cantly lower at T12 than at T0 (−0.52 (0.58) mmol l−1; P <
0.005), but not significantly lower when compared to BL values
(−0.18 (0.50) mmol l−1). As with LDL, the concentration of
serum TC at T0 and BL were both significantly correlated with
the change in this variable at T12 (R = 0.804, P < 0.001 and R =
0.722, P < 0.005, respectively), with the greatest reduction
being observed in those with higher total cholesterol concen-
trations at T0 or BL.
However, there was no such association in the women, irre-
spective of whether values at BL or T0 were used (R = 0.145,
P = 0.530 and R = 0.087, P = 0.710 respectively).
Circulating concentration of TAG was not diﬀerent between
sexes at BL and did not change over the pre-intervention or
intervention period in the whole cohort or within sex.
Insulin resistance
As with other normal weight cohorts reported in the literature,
HOMA-IR values did not indicate the presence of fasting
insulin resistance at the start of the study (Table 1). Men and
women were matched for HOMA-IR at BL and this measure
did not alter in the whole cohort, as a result of the pre-inter-
vention period. However, HOMA-IR changed over the interven-
tion period (P < 0.005), with median HOMA-IR increasing from
1.71 [1.34–2.23] at T0 to 2.05 [1.67–2.46] at T6 (P < 0.025), but
returning to pre-intervention values at T12 (1.65 [1.25–2.25]).
Haematological measures
Erythrocyte parameters. Haematological measures were col-
lected in 23 individuals (8M : 15F) and in these participants,
males had significantly greater circulating haemoglobin (Hb)
than females (Table 4; P < 0.01). During the intervention, a
reduction in Hb concentration was observed in men and
women (P < 0.05 for each sex), with the response being similar
Fig. 2 Mean serum LDL (A) and HDL cholesterol (B) across the pre-
intervention and intervention period in women ( ) and men ( ). *P <
0.05 compared with BL, ††P < 0.01 compared with start of intervention
(T0). Error bars indicate the standard error of the mean.
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between sexes. Hb concentration in males was significantly
lower at T12 (P < 0.025) when compared to the start of the
study, and in females this variable was significantly lower at T6
(P < 0.025; Table 4).
Results for Hb appeared to be related to red cell count
(RCC), as Mean Corpuscular Haemoglobin (MCH) was similar
between sexes at the start of the study and this variable did
not change in men or women over the study period, whereas
the pattern of change in RCC mirrored those already described
for Hb (Table 4). Mean Corpuscular Volume (MCV) did reduce
over the intervention in both men and women (P < 0.05 in
each case), but a MCV below normal values was only detected
in one female at T6, and three at T12. Pencil cells and the pres-
ence of other poikilocytes were not reported.
One female participant developed an Hb concentration and
RCC below the normal range during the meat reduction period
(Hb 112 g l−1 at T6 and 114 g l−1 at T12; RCC 3.6 and 3.7 × 1012
cells per l at T6 and T12 respectively). On clinical advice this
individual was not withdrawn from the intervention at week 6
(T6) when reduced Hb and RCC was first noted, and at a
follow-up (2 months after the intervention had been com-
pleted), Hb and RCC had reverted back to being within the
normal range.
Leukocyte parameters. There were no statistical diﬀerences,
between sex, for white cell, neutrophil and platelet count at BL
and response to the intervention was similar in men and
women. During the RPM reduction phase of the study, a
change in all three variables was detected (P < 0.005 in each
case), with cell counts being significantly lower at T6 and T12
when compared to starting values. Indeed, 47% of females
and 50% of males had a fall in neutrophil count of >1 × 109
l−1, with four women and one man demonstrating a neutro-
phil count just below the normal range at T6. At T12, only one
woman still demonstrated a neutrophil count below normal
levels, although 40% of the females and 25% of males still had
a neutrophil count which was >1 × 109 l−1 below starting
values. All white cell parameters returned to being within the
normal range at the 2-month follow-up.
Discussion
Omnivorous diets high in RPM have been implicated in the
development of a number of chronic diseases, including
CVD.7,8 Analysis of the combined Health Professionals Study
(37 698 men) and Nurses Health Study (83 644 women)
suggested that reducing red meat intake by 1 portion (equi-
valent of 85 g fresh red meat) per day could reduce mortality
risk by 7–18%,9 whilst in a modelling study, Aston et al.
reported a 2.5-fold diﬀerence in RPM intake between the
highest and lowest quintiles of consumers, and predicted that
by moving from the highest to the lowest quintile of processed
(but not fresh) meat, men could potentially reduce coronary
heart disease risk by 20.6% and women by 11.1%.18 Although
processed meat is generally associated with high intakes of
salt and other preservatives (such as nitrites and nitrates)
which may influence hypertension, the mechanisms whereby
RPM consumption is associated with CVD remain to be fully
elucidated, with the impact of associated SFA on plasma LDL
cholesterol often suggested to be the primary eﬀect.19
However, in the combined Health Professionals Study and
Nurses Health Study, residual eﬀects of meat consumption
were apparent even after accounting for diﬀerences in SFA
(and dietary cholesterol) intake.9
In the present study, median RPM consumption decreased
from 1.3 portions a day to 0.7 portions, and this dietary
change appeared to be a strong enough stimulus to bring
about a reduction in LDL in the men but not women. Any
potential benefit of this was, at least partly, oﬀset by a decrease
in HDL. This obviously leads to questions concerning compli-
ance of the female participants. It was possible that dietary
records for females in the current study did not reflect actual
behaviour and they did not reduce their RPM intake, or any
changes made did not impact dietary fat intake to the same
degree as the men. However, subjectively authors did not note
a diﬀerence in engagement with the study protocol between
sexes, and several couples were included in the cohort, such
that meals were being shared by both individuals within the
couple. Indeed, although results should be viewed with
caution (due to limitations associated with dietary records),
numerical changes in absolute intake and percentage contri-
bution of SFA, PUFA, trans-fats and cholesterol to total EI,
during the intervention were not diﬀerent in men and women.
Moreover, similar responses in haematological variables were
observed, suggesting that whatever aspect of the intervention
was driving these changes was similar in both sexes. Average
TC concentrations in women have been shown to vary during
Table 4 Haematological parameters at BL and during the intervention
(T6 and T12) in a sub-set of the study cohort (15F : 8M). Where diﬀer-
ences between sex were identiﬁed at BL, data for men and women are
displayed separately. Where values at BL were the same between sex,
data have been combined and values for all participants (n = 23) are
reported. RCC, red cell count. Hb, haemoglobin. MCH, mean corpuscu-
lar haemoglobin. MCV, mean corpuscular volume. WCC, white cell
count. Mean values are expressed with the standard deviation in par-
entheses; median values1 are shown with the 25th and 75th percentile in
square brackets. Comparisons to BL *P < 0.025, **P < 0.01
BL T6 T12
RCC (x1012 l−1) Men 4.95 (0.28) *4.73 (0.23) *4.83 (0.25)
Women 4.49 (0.40) *4.32 (0.32) 4.40 (0.34)
All 4.65 (0.42) **4.46 (0.35) **4.54 (0.37)
Hb1 (g l−1) Men 146 [144–150] 141 [134–144] *139 [137–147]
Women 134 [127–141] *131 [125–134] 133 [126–136]
All 141 [132–145] **133 [129–138] *136 [128–139]
MCH (pg) All 29.8 (1.13) 29.8 (1.02) 29.6 (1.05)
MCV (fl) Men 86.0 (1.77) *84.6 (1.85) 84.6 (1.60)
Women 89.1 (3.35) 88.9 (2.95) **88.0 (3.07)
All 88.0 (3.22) 87.4 (3.30) **86.8 (3.08)
WCC1
(x109 l−1)
All 6.9 [5.8–7.5] **5.0 [4.1–6.0] **5.2 [4.8–5.8]
Neutrophils1
(x109 l−1)
All 3.7 [3.1–4.3] **2.6 [2.1–3.8] **2.7 [2.4–3.2]
Platelets1
(x109 l−1)
All 230 [221–242] **207 [189–236] *217 [198–246]
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the menstrual cycle by approximately 0.2 mmol l−1 20 and this
variance is of a similar magnitude to the diet-induced
reduction in TC seen in males (compared with BL values). In
the current protocol, blood sampling time points were not
standardised for point in the menstrual cycle, and it is poss-
ible that normal fluctuations in TC were masking diet-induced
changes in women. However, we propose that a more likely
explanation for this lack of response in women is that the
eﬀect of RPM reduction on total fat, SFA and cholesterol
intake, despite being of the same magnitude as achieved in
men, was not a suﬃcient stimulus to induce blood lipid
changes in women. Diets designed to reduce LDL in those at
risk of CVD aim to lower SFA to approximately 5% of total EI,21
whereas reduction of SFA in the current study was much
smaller (control period 12.9% of EI; intervention period 11.5%
of EI). In humans there does not appear to be diﬀerences in
intestinal fat absorption between the sexes22 but diﬀerences in
lipid metabolism, such as postprandial LDL clearance rates23
may be suﬃcient to influence the eﬀect that small dietary
changes have on circulating lipids.
Despite the current study participants demonstrating lipo-
protein cholesterol concentrations within the ‘normal’ range,
and as a result the range to assess a change to these para-
meters was narrow, a significant reduction in LDL and HDL
was induced over the intervention period in men. Although
these findings may have been confounded by changes in
behaviour during the pre-intervention period, which tended to
elevate TC and LDL from BL concentrations, those with total
and LDL cholesterol concentrations in the upper ranges of
normal at BL still demonstrated greater reduction in this vari-
able over the intervention period compared with those starting
with lower TC and LDL levels. This suggests that in males
those who have the highest level of these CVD risk factors may
benefit most from reducing their RPM intake.
Although meat-based diets are rich in the essential micro-
nutrients required for haemopoiesis, the extent to which the
intervention appeared to impact RCC, WCC and platelet count
was surprising. In Western societies, reduced RPM intake is
now being advocated.13,14 However, veganism is associated
with a risk of vitamin B12 deficiency,
24 and established veg-
etarians have been shown to have reduced RCC and WCC com-
pared to age matched omnivores.25 Unfortunately, these para-
meters are rarely reported in dietary interventions that acutely
reduce meat intake, but reductions in blood cell counts were
not observed when older omnivores changed to a vegetarian
diet for 12 weeks.26 No detectable changes in dietary intake of
copper, iron, zinc, or the B vitamins were noted from the diet
diaries over the study. However, 4-day recording is not
suﬃcient to reliably investigate changes in micronutrient
intake.27
A strength of the current study was that the longitudinal
study design allowed changes over time, within individuals, to
be assessed, a feature that is not possible with cross-sectional
studies used to infer links between dietary variables and blood
lipid profile. However, a notable weakness was that it is likely
that small changes to the habitual diet (in relation to RPM
intake) occurred during the pre-intervention period, which
may have led to an overestimation of the dietary change and
(in males) the serum lipid reduction that could be achieved by
the intervention. Indeed, anecdotally, several participants
reported using up their meat stores prior to starting the inter-
vention, and a strong trend for increased intake of protein
from RPM was noted at T0. Despite the limitations, correlation
findings illustrate the impact that RPM consumption and
dietary fat content could have on LDL parameters in healthy
men and identified that males and premenopausal women
may respond diﬀerently to small dietary changes.
Experimental
Trial design
A single group, longitudinal study design was adopted, com-
prising an initial 4-week baseline (‘pre-intervention’) period
followed by a 12-week intervention. To maximise the statistical
power of the study, a within subject design was favoured, but
behavioural interventions do not lend themselves to a random-
ised cross-over design, as any behaviour change message deli-
vered during a first phase could aﬀect behaviour at the second.
Assessment visits to the laboratory were scheduled before and
after each period; BL pre-baseline period (week-4), T0 post
baseline period/start of intervention (week 0) and T12 at end
of the intervention period (week 12), with an interim assess-
ment (T6) made at the intervention midpoint (week 6).
This study was conducted in accordance with the guidelines
laid down in the Declaration of Helsinki of 1975 (as revised
in 1983) and all procedures involving human participants
were approved by the University of Nottingham Medical
School Ethics Committee (reference A18062015). Written
informed consent was obtained from all subjects. The study
was registered at http://www.ClinicalTrials.gov (reference
NCT02907112).
Participants
Forty-six (23 males (M) : 23 females (F)) volunteers from the
general population of Nottinghamshire, UK attended the
David Greenfield Human Physiology Unit (Queen’s Medical
Centre, Nottingham, UK) for an initial medical screening visit
to confirm health status and frequency of eating RPM; a
threshold for the weight of meat consumed was not used as a
recruitment criteria. Blood pressure (BP) was measured at the
left upper arm (after lying semi-supine for 5 min) using auto-
mated oscillometry (Dynamap Pro 1000; GE Medical,
Milwaukee, USA), and body mass index (BMI) was calculated
from measured height and weight. If participants were suitable
to take part with regards to their health questionnaire,
reported habitual meat intake in a food frequency question-
naire (across 11 meat and 1 poultry categories) and BMI
measures (BMI < 28 kg m−2), a blood sample was then taken
from a forearm vein to assess full blood count, urea, and elec-
trolytes (Dept of Pathology Queen’s Medical Centre,
Nottingham, UK). Those taking lipid-lowering medication, or
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who reported using nutritional strategies to lower their chole-
sterol, were excluded. Participants were accepted onto the trial
if they reported habitual consumption of 4 or more portions of
red and/or processed meat per week (with 3 or more of these
being consumed as main meals), they did not have food aller-
gies related to soya or mycoprotein, and did not demonstrate
any clinically significant abnormalities on screening.
Eligibility criteria were not altered during the recruitment
period.
Study protocol
After recruitment, participants were asked to record all food
intake (including snacks and drinks), in a diet diary, for 4 days
(3× week or work days, and 1× weekend or rest day) prior to BL
visit. This provided a baseline assessment of dietary macronu-
trient, energy and meat intake. Individuals were asked to com-
plete further 4-day diet diaries in the week before assessment
visits T0, T6 and T12 (weeks-1, 5, and 11), to assess any
changes in macronutrient or energy intake, and meat con-
sumption, which may have occurred as a consequence of parti-
cipating in the study. Household measures were used to esti-
mate portion size, and diaries were subsequently analysed
using a food composition database (Nutritics, Dublin, Eire). To
calculate habitual diet composition, a mean daily intake was
obtained from all 4 days of each recording period, and macro-
nutrient composition was expressed as a percentage of total
energy intake. This individual information was combined to
produce grouped data for the whole cohort and for males and
females. To identify changes to habitual dietary behaviour, all
foods recorded in the individuals’ diet diaries were allocated
to 12 food groups, 7 of which represented major dietary
protein contributors; red and processed meat, seafood (fish
and shell fish), chicken, dairy (milk, cheese, yogurt and eggs),
pulses and nuts, mycoprotein and ‘starchy’ foods (breads,
cereals, rice and potato). Prior to food group allocation, com-
ponents of composite foods were calculated from recipes pro-
vided by the participants, or where relevant, from ingredient
information provided by manufacturers. The macronutrient
composition of each food item within categories was calcu-
lated from weight consumed, and within each of these 7 food
group categories, an average value for each macronutrient
(protein, fat, carbohydrate) was produced for every individual.
These were combined to form group means as before. Mean
protein intake contributed by the RPM category was used to
identify any changes to intake over the control and interven-
tion period. Where RPM content of foods, such as sausages,
could not be identified, an assumption was made that the
protein content of that food was provided by the meat
component.
Assessment visits took place in the morning after the indi-
vidual had fasted from midnight the night before. Initially,
measurement of body mass was made to the nearest 0.1 kg
using a Seca 882 Digital Scale (Birmingham, UK). Participants
were then asked to rest, semi-supine, on a couch and esti-
mation of body composition was made using bioelectrical
impedance (BodyStat Ltd, Douglas, Isle of Man), with resting
blood pressure measured as described above. A 5 ml fasting
blood sample was taken for determination of serum insulin,
total cholesterol (TC), HDL, LDL, TAG and whole blood
glucose. Four millilitres of blood were placed into a Vacutainer
SST™ tube (Becton, Dickinson and Co, USA) and left at room
temperature for 20 min to clot. The sample was then centri-
fuged for 10 min (3000 rcf, 4 °C), the serum was transferred to
labelled micro-tubes, and stored at −80 °C until analysis for
lipids and insulin concentration. The remaining blood collec-
tion was transferred into a fluoride heparin microtube
(Sarstedt, Germany), mixed well and whole blood glucose then
assessed within 10 min using the glucose oxidase method
(Yellowsprings Inc., Yellowsprings, CO, USA; within assay pre-
cision being 1%). Homeostatic assessment of insulin resis-
tance (HOMA-IR), an index of fasting insulin resistance, was
subsequently calculated from insulin and glucose concen-
tration according to standard methods.28
In a convenience sample of 23 individuals, who represent
all those recruited in the period between January and April
2016 (8M : 15F), an additional 1 ml of blood was taken at
T6 and T12, placed into a Vaccutainer EDTA tube (Becton,
Dickinson and Co, USA), and sent to the Clinical Pathology
Laboratories at Queens Medical Centre (Nottingham University
Hospitals NHS Trust, UK) for determination of full blood
count using an XN-9000 automated cell counter (Sysmex UK
Ltd, Milton Keynes, UK). Reference values provided by these
laboratories were used to define the normal range of haemato-
logical parameters; Hb 130–180 g l−1, MCH 28–33 pg, RCC
4.2–6.5 × 1012 l−1, MCV 84–102 fl, WCC 4–11 × 109 l−1, neutro-
phils 2.0–7.5 × 109 l−1, platelets 150–450 × 109 l−1.
Intervention
After initial measurements (BL; week-4), participants were
asked not to make any changes to their lifestyle and to con-
tinue their habitual diet until the second visit (T0; week 0)
when a second assessment was made (‘pre-intervention’
period). The 12 weeks intervention period began on the day
after the second study visit. At this point, participants were
given information regarding how meat intake could safely be
reduced in their diet, including a recipe book containing ideas
for meals using meat analogues (meat-free or reduced-meat
products that resemble commonly consumed meat foodstuﬀs)
and plant foods which are rich sources of protein. However,
beyond the request to reduce RPM intake by 50%, participants
were not given set menus to follow, or any stipulation on
which strategy/strategies they were to use to achieve their
meat-reduction target. To assist with this reduction in RPM
intake, a range of frozen and chilled meat-free, and frozen
reduced-meat products were available for the participants to
use if they wished. These included soya (Tescos PLC, Welwyn
Garden City, UK) or mycoprotein (Quorn™) mince, Quorn™
sausages, Quorn™ ‘meatballs’ and Quorn™ ‘steak strips’ (all
Quorn™ products were provided by Marlow Foods, Stokesley,
UK). The frozen reduced-meat products included pork sau-
sages, beef meatballs, beef mince and beef burgers manufac-
tured specifically for the project by DuPont (Aarhus, DK), and
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had 50% of the meat content replaced with soya or mycopro-
tein. In addition, 2 chilled mycoprotein products were oﬀered
as an alternative to delicatessen meats (Quorn™ ‘ham’,
Quorn™ ‘Turkey’ slices), and a range of dried beans (red
kidney, haricot, black turtle), pulses (chick peas, green and red
lentils) and grains (quinoa) were also available. Pulses, lentils
and grains were supplied by A Poortman Ltd (London, UK).
Monthly newsletters and weekly email contact with the study
participants was maintained over the intervention period to
improve compliance, to identify any problems and to arrange
further food deliveries if required.
In those who had demonstrated blood cell counts or Hb
levels below the normal range, a follow-up assessment of
haematological parameters was arranged 8 weeks after the end
of the study.
Analytical methods
Serum insulin was assessed using a human-specific radio-
immunoassay (Merck Millipore, Billerica, MA, USA), with an
intra-assay coeﬃcient of variation (CV) of 4.41%, and an inter-
assay CV of 10.53%. TAG, TC, LDL and HDL were measured
using enzymic photometric methods (Horiba Medical,
Montpellier, France), and the intra-assay CVs were 2.16%,
2.63%, 2.21% and 0.77% respectively, with inter-assay CVs
being 3.27%, 2.6%, 4.77% and 4.72%, respectively.
Statistical methods
All data were coded and analysed using SPSS version 22.0
(Statistical Package for the Social Sciences 2013). Data were
initially checked for normality of distribution (using criteria of
skewness and kurtosis z-score between −1.96 and 1.96). Data
with a normal distribution are described in the text and tables
as the mean with the standard deviation in parentheses, and
displayed in figures as the mean with error bars indicating the
standard error of the mean (SEM). Data which did not show a
normal distribution are displayed in the text and tables as the
median with the 25% and 75% percentile values shown in
square brackets.
Between sex comparisons at a single time point were made
using unpaired Student’s t-test or Mann–Whitney U as appro-
priate, with assessment of responses between sexes within
study periods (pre-intervention and intervention), carried out
using 2-way repeated measures ANOVA. Violation of the
assumption of sphericity was assessed using Mauchly’s test,
and where appropriate the Greenhouse-Geisser statistic used
to determine the significance level. Where diﬀerences in BL
values or responses were noted between sexes, data for men
and women were analysed and are reported separately. Where
no diﬀerences were observed, data were analysed and are
reported for the whole cohort to improve statistical power.
One-way repeated measures ANOVA (or Friedman’s test) was
used to investigate changes across the intervention (in the
whole cohort, or within sex) and across the pre-intervention
period paired Student’s t-test, or Wilcoxon signed ranks was
used. All analysis used a two-tailed assessment and statistical
significance was assumed where P < 0.05. Post-hoc analysis,
with Bonferroni correction was used to probe diﬀerences in
repeated measures data, and multiple regression analysis uti-
lised to investigate relationships between dietary intake of
macronutrients and serum lipid concentration.
Sample size
Pilot data generated within the research group was used to
inform the variability of serum TC and LDL concentration in a
young, healthy male and female population (n = 25), and the
magnitude of change which could be expected with a dietary
intervention. In this pilot cohort, average TC was 4.45 (0.54)
mmol l−1 and a reduction of 0.41 mmol l−1 was observed after
a 4 weeks period of red and processed meat reduction. From
these data, a sample size of sixteen participants was predicted
to be able to detect a diﬀerence in mean TC concentration
with a statistical power at the level of 80% in the current study.
Average LDL concentration for this group was 2.40 (0.37) mmol l−1
and a reduction of 0.25 mmol l−1 was observed. Sample size
expected to power this variable would be 20 individuals. To
allow investigation of any eﬀects of the intervention within sex,
it was proposed that 20 men and 20 women were recruited.
Conclusions
It was possible for omnivores to approximately halve their
RPM intake over a 12 weeks period, but this dietary change
was accompanied by an unfavourable eﬀect on blood cell
counts. There was a suggestion that reducing red meat intake
was of greatest benefit to men with higher LDL and total chole-
sterol concentration at the start of the study, whilst blood lipid
profiles in women were unaﬀected by reported dietary
changes. In future dietary interventions modifying meat
intake, close monitoring of haematological parameters and
detailed dietary assessment would be recommended.
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